A detailed history of Lazard Asset Management LLC transactions in Viatris Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 275 shares of VTRS stock, worth $3,575. This represents 0.0% of its overall portfolio holdings.

Number of Shares
275
Previous 275 -0.0%
Holding current value
$3,575
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.05 - $12.02 $19,366 - $23,162
-1,927 Reduced 87.51%
275 $2,000
Q1 2024

May 14, 2024

BUY
$11.27 - $13.53 $21,604 - $25,937
1,917 Added 672.63%
2,202 $26,000
Q4 2023

Feb 14, 2024

BUY
$8.77 - $10.85 $491 - $607
56 Added 24.45%
285 $3,000
Q2 2023

Aug 14, 2023

SELL
$9.02 - $10.29 $342 - $391
-38 Reduced 14.23%
229 $2,000
Q1 2023

May 15, 2023

BUY
$9.2 - $12.26 $736 - $980
80 Added 42.78%
267 $2,000
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $3,400 - $4,508
-390 Reduced 67.59%
187 $2,000
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $4,892 - $6,422
577 New
577 $4,000
Q1 2022

May 13, 2022

SELL
$9.81 - $15.4 $10 Million - $15.7 Million
-1,022,371 Closed
0 $0
Q4 2021

Feb 09, 2022

SELL
$12.09 - $14.68 $67,933 - $82,486
-5,619 Reduced 0.55%
1,022,371 $13.8 Million
Q3 2021

Nov 15, 2021

SELL
$13.25 - $15.13 $1.15 Million - $1.31 Million
-86,625 Reduced 7.77%
1,027,990 $13.9 Million
Q2 2021

Aug 12, 2021

SELL
$12.97 - $16.15 $6.58 Million - $8.2 Million
-507,549 Reduced 31.29%
1,114,615 $15.9 Million
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $1.61 Million - $2.19 Million
-118,260 Reduced 6.79%
1,622,164 $22.7 Million
Q4 2020

Feb 11, 2021

BUY
$14.3 - $18.74 $24.9 Million - $32.6 Million
1,740,424 New
1,740,424 $32.6 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.